These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1653079)

  • 1. Recurrent kidney stones: causes and diagnostic criteria in patients from Campania (southern Italy).
    Nunziata V; Di Giovanni G; Giannattasio R; Lettera AM; Mancini M
    Br J Urol; 1991 Aug; 68(2):125-31. PubMed ID: 1653079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocrine and metabolic aspects of urology. Aetiology of stone formation in 145 renal stone patients.
    Transbol I; Frydendal N
    Acta Chir Scand Suppl; 1973; 433():137-53. PubMed ID: 4513504
    [No Abstract]   [Full Text] [Related]  

  • 3. Utility of blood tests in screening for metabolic disorders in kidney stone disease.
    Eyre KS; Lewis F; Cui H; Grout E; Mihai R; Turney BW; Howles SA
    BJU Int; 2021 May; 127(5):538-543. PubMed ID: 32967050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive value of kidney stone composition in the detection of metabolic abnormalities.
    Pak CY; Poindexter JR; Adams-Huet B; Pearle MS
    Am J Med; 2003 Jul; 115(1):26-32. PubMed ID: 12867231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Family history of renal stones in recurrent stone patients.
    Ljunghall S; Danielson BG; Fellström B; Holmgren K; Johansson G; Wikström B
    Br J Urol; 1985 Aug; 57(4):370-4. PubMed ID: 4027504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal tubular acidosis in recurrent renal stone formers.
    Mateos Antón F; García Puig J; Gaspar G; Martínez ME; Ramos T; Martínez Piñeiro JA
    Eur Urol; 1984; 10(1):55-9. PubMed ID: 6698089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Metabolic changes in the patient with recurring lithiasis. Our cases].
    Miján Ortiz JL; Muñoz Torres M; Puebla Ceverino M; García Victor F; Céspedes Mas S; Zuluaga Gómez A; Escobar Jiménez F
    Arch Esp Urol; 1991; 44(1):55-7. PubMed ID: 2064424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interrelationships between circulating vitamin D metabolites in normocalciuric and hypercalciuric renal stone formers.
    Gascon-Barré M; D'Amour P; Dufresne L; Perreault JP
    Ann Nutr Metab; 1985; 29(5):289-96. PubMed ID: 3876804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of renal calculi.
    Coe FL; Favus MJ
    Adv Intern Med; 1980; 26():373-92. PubMed ID: 7013442
    [No Abstract]   [Full Text] [Related]  

  • 10. Simplified protocol for biochemical evaluation of recurrent renal calcium stone disease.
    Thode J; Finnerup B; Parvin C; Holmegaard SN; Skaarup P; Sørensen OH; Transbøl I
    Miner Electrolyte Metab; 1988; 14(5):288-96. PubMed ID: 2845241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ambulatory diagnostic evaluation of 389 recurrent renal stone formers. A proposal for clinical classification and investigation.
    Wikström B; Backman U; Danielson BG; Fellström B; Johansson G; Ljunghall S
    Klin Wochenschr; 1983 Jan; 61(2):85-90. PubMed ID: 6843037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal calculi associated with incomplete distal renal tubular acidosis.
    Konnak JW; Kogan BA; Lau K
    J Urol; 1982 Nov; 128(5):900-2. PubMed ID: 7176046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent renal calculi. Causes and prevention.
    Coe FL; Parks JH
    Hosp Pract (Off Ed); 1986 Mar; 21(3A):49-57. PubMed ID: 3081562
    [No Abstract]   [Full Text] [Related]  

  • 14. Metabolic basis of renal-stone disease.
    Broadus AE; Thier SO
    N Engl J Med; 1979 Apr; 300(15):839-45. PubMed ID: 34098
    [No Abstract]   [Full Text] [Related]  

  • 15. [Functional evaluation in patients with kidney calculi].
    Stojimirović B
    Srp Arh Celok Lek; 1998; 126(9-10):394-8. PubMed ID: 9863414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic abnormalities associated with calyceal diverticular stones.
    Auge BK; Maloney ME; Mathias BJ; Pietrow PK; Preminger GM
    BJU Int; 2006 May; 97(5):1053-6. PubMed ID: 16643491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hypercalciuria, primary hyperparathyroidism and calcium nephrolithiasis].
    Ivanov I
    Vutr Boles; 1984; 23(2):1-7. PubMed ID: 6331011
    [No Abstract]   [Full Text] [Related]  

  • 18. The hypercalciurias. Causes, parathyroid functions, and diagnostic criteria.
    Pak CY; Oata M; Lawrence EC; Snyder W
    J Clin Invest; 1974 Aug; 54(2):387-400. PubMed ID: 4367891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of calcium urolithiasis in ambulatory patients: comparison of results with those of inpatient evaluation.
    Pak CY; Fetner C; Townsend J; Brinkley L; Northcutt C; Barilla DE; Kadesky M; Peters P
    Am J Med; 1978 Jun; 64(6):979-87. PubMed ID: 207183
    [No Abstract]   [Full Text] [Related]  

  • 20. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.